| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50242-917-01 | 50242-917 | HUMAN PRESCRIPTION DRUG | TECENTRIQ | atezolizumab | INJECTION, SOLUTION | INTRAVENOUS | 20160518 | N/A | BLA | BLA761034 | Genentech, Inc. | ATEZOLIZUMAB | 1200 mg/20mL | 1 VIAL, SINGLE-USE in 1 CARTON (50242-917-01) / 20 mL in 1 VIAL, SINGLE-USE |
| 50242-917-86 | 50242-917 | HUMAN PRESCRIPTION DRUG | TECENTRIQ | atezolizumab | INJECTION, SOLUTION | INTRAVENOUS | 20160811 | N/A | BLA | BLA761034 | Genentech, Inc. | ATEZOLIZUMAB | 1200 mg/20mL | 1 VIAL, SINGLE-USE in 1 CARTON (50242-917-86) / 20 mL in 1 VIAL, SINGLE-USE |
| 50242-918-01 | 50242-918 | HUMAN PRESCRIPTION DRUG | TECENTRIQ | atezolizumab | INJECTION, SOLUTION | INTRAVENOUS | 20190308 | N/A | BLA | BLA761034 | Genentech, Inc. | ATEZOLIZUMAB | 840 mg/14mL | 1 VIAL, SINGLE-USE in 1 CARTON (50242-918-01) / 14 mL in 1 VIAL, SINGLE-USE |